AstraZeneca’s Camizestrant Gets EU Approval for Advanced Breast Cancer

Precision Oncology’s Breakthrough: Camizestrant’s EU Green Light

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has just delivered a landmark decision: eight new medicines recommended for approval in a single meeting, including two firsts that could reshape cancer treatment in Europe. Among them, AstraZeneca’s Etcamah (camizestrant) has secured a positive opinion for treating advanced breast cancer in patients … Read more

Catalonia Launches First Astrazeneca Thrombosis Trial in Barcelona: Key Insights and Updates

Landmark Vaccine Thrombosis Lawsuit Begins in Catalonia, Sparking Global Interest BARCELONA, Spain – A groundbreaking legal battle concerning the AstraZeneca COVID-19 vaccine (Vaxzevria) and its potential link to thrombosis is set to commence in Barcelona on monday, march 17, at 12 p.m. The trial, the first of its kind in catalonia, centers on Pedro García, … Read more

Thailand’s First mRNA Vaccine Recipient with Autoimmune Disease: Doctor Issues Urgent Warning

mRNA Vaccine Linked to Rare Autoimmune Disease in Thailand: Doctor’s⁢ Case Study A concerning case study from Thailand ⁢details a patient’s severe ‍autoimmune reaction following an mRNA vaccine, ⁢prompting discussion about potential long-term⁣ effects and vaccine⁤ safety. Dr. Manoon Leechawengwong, a‍ respiratory disease specialist, shared the details on his Facebook page, highlighting the unique challenges … Read more